- Current report filing (8-K)
January 27 2009 - 6:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC
20549
_______________
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported):
January 26, 2009
AVIGEN, INC.
(Exact name of registrant as specified in charter)
Delaware
|
000-28272
|
13-3647113
|
(State or other jurisdiction of
|
(Commission File Number)
|
(I.R.S. Employer Identification
|
incorporation)
|
|
No.)
|
1301 Harbor Bay Parkway
Alameda,
California 94502
(Address of principal
executive offices and zip code)
Registrants telephone number, including
area code:
(510) 748-7150
______________________________
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On January 26, 2009, Avigen, Inc. issued a
press release stating that it will review and consider the unsolicited tender
offer made by BVF Acquisition LLC a wholly owned subsidiary of Biotechnology
Value Fund, L.P. (collectively, BVF), to purchase all of the outstanding
shares of Avigen Inc.s common stock for $1.00 per share.
A copy of the press release is attached as
Exhibit 99.1 and is incorporated into this current report by reference.
Item 9.01. Financial Statements and
Exhibits.
(d) Exhibits
Exhibit No.
|
|
Description
|
99.1
|
|
Press release issued by Avigen, Inc. on January 26,
2009.
|
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 26,
2009
|
|
AVIGEN, INC.
|
|
|
By:
|
/s/ Andrew A. Sauter
|
|
|
Andrew A. Sauter
|
|
|
Chief Financial Officer
|
INDEX TO EXHIBITS
Exhibit No.
|
|
Description
|
99.1
|
|
Press release issued by Avigen, Inc. on January 26,
2009.
|
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Oct 2023 to Oct 2024